Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials is a research paper published in The Journal of Rheumatology (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAAA NIH HHS
Grant: HHSN275201000003C
NIGMS NIH HHS
Grant: T32 GM086330
FDA HHS
Grant: R01 FD006099
NICHD NIH HHS
Grant: R01 HD076676
NIAID NIH HHS
Grant: HHSN272201500006C
NICHD NIH HHS
Grant: K23 HD090239
NICHD NIH HHS
Grant: HHSN275201000003I
NICHD NIH HHS
Grant: R13 HD102136
NHLBI NIH HHS
Grant: R33 HL147833
NCATS NIH HHS
Grant: UL1 TR001422
NCATS NIH HHS
Grant: UL1 TR002553
NICHD NIH HHS
Grant: R01 HD083003
NICHD NIH HHS
Grant: R01 HD096435
NIAID NIH HHS
Grant: R21 AI132677
FDA HHS
Grant: U18 FD006298
NIAID NIH HHS
Grant: HHSN272201300017I
NIAMS NIH HHS
Grant: U19 AR069522
NICHD NIH HHS
Grant: UG1 HD068258
NIAID NIH HHS
Grant: HHSN272201300017C
NIAMS NIH HHS
Grant: K23 AR075874
NIAID NIH HHS
Grant: K24 AI143971
NCATS NIH HHS
Grant: U24 TR001608
National Institutes of Health
Grant: 4R33HL147833-03
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
National Institutes of Health
Grant: 3U24TR001608-05S1
Admin Supplement - Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)
National Institutes of Health
Grant: 5F32AR008177-02
THE MDX DIAPHRAGM &THE IMMUNOLOGY OF MYOBLAST TRANSFER
National Institutes of Health
Grant: 5U18FD006298-03
Global Pediatric Clinical Trials Network
National Institutes of Health
Grant: 5R21AI132677-02
The relationship between maternal ZIKV-specific and ADE antibodies and fetal outcome
National Institutes of Health
Grant: 2T32GM086330-06
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
National Institutes of Health
Grant: 1U19AR069522-01
Enhancing Meaningfulness and Usefulness of Pediatric and Caregiver PROMIS Measures Across Illness Groups
National Institutes of Health
Grant: 1R13HD102136-01
Pediatric Critical Care Research Landscape - A National Expert Conference
National Institutes of Health
Grant: 5R01HD076676-04
Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children
National Institutes of Health
Grant: 1K23HD090239-01
Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass
National Institutes of Health
Grant: 5U24TR001608-03
Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)
National Institutes of Health
Grant: 5UG1HD068258-08
NICHD Maternal-Fetal Medicine Units (MFMU) Network
National Institutes of Health
Grant: 5K24AI143971-05
Mentoring in Clinical Pharmacology and Early Phase Trials
National Institutes of Health
Grant: 1UL1TR002553-01
Duke CTSA
National Institutes of Health
Grant: 3R01HD076676-02S1
Phsysiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children-Informationist Supplement
National Institutes of Health
Grant: 1R01FD006099-01
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
National Institutes of Health
Grant: 1R01HD096435-01
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity
Wellcome Trust
Wellcome Trust
FWCI
1.84
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals